Company Filing History:
Years Active: 2014-2017
Title: Sung Jae Pyun: Innovator in Antimicrobial Pharmaceutical Composition
Introduction
Sung Jae Pyun is a distinguished inventor based in Seoul, South Korea, known for his significant contributions to the field of pharmaceuticals. With a total of five patents to his name, Pyun has emerged as a key figure in the development of antimicrobial agents that are both effective and safe for consumption.
Latest Patents
Among his latest innovations, Pyun has developed two notable patents: R-7-(3-aminomethyl-4-methoxyimino-3-methyl-pyrrolidin-1-yl)-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-[1,8]naphthyridine-3-carboxylic acid and L-aspartic acid salt, along with a pharmaceutical composition containing these compounds intended for antimicrobial use. These patented compounds demonstrate enhanced solubility and reduced toxicity compared to traditional agents, such as hydrochloride and other salts, making them particularly useful for both oral and injectable administration.
Career Highlights
Throughout his career, Sung Jae Pyun has worked with various prestigious companies, including Arimed Inc. and Aribio Co., Ltd. His expertise and innovative approach have significantly influenced the pharmaceutical landscape, particularly in the area of antimicrobial treatments.
Collaborations
In his professional journey, Pyun has collaborated with eminent colleagues, such as Dong Rack Choi and Jin Wook Yang. These partnerships have enabled him to refine his inventions and expand the potential applications of his patented compounds within the pharmaceutical industry.
Conclusion
Sung Jae Pyun continues to make strides in the field of pharmaceuticals through his research and inventions. His work on antimicrobial agents not only addresses critical health challenges but also sets the stage for future innovations in drug development. As he moves forward, Pyun's contributions are poised to leave a lasting impact on the industry.